KPTICongressional Stock Trades
Karyopharm Therapeutics Inc.
Pharmaceutical Preparations
Congressional stock trades in Karyopharm Therapeutics Inc. (KPTI) from House and Senate STOCK Act filings. See which members of Congress bought or sold, disclosed amounts, and filing dates.
Total Trades
1
Politicians Trading
1
Last Traded
Feb 20, 2025
Trading History
| Politician | Notified | Traded | Type | Amount | Change |
|---|---|---|---|---|---|
| Ashley MoodyR | Mar 22, 2025 | Feb 20, 2025 | Sell | $1,001 - $15,000 | -79.45% |
Price History
About Karyopharm Therapeutics Inc.
Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company focused on novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company conducts research focused on intracellular communication between the nucleus and cytoplasm and has developed small-molecule compounds that inhibit exportin 1 (XPO1), a nuclear export protein. It is focused on marketing XPOVIO (selinexor).